Novavax Covid-19 Vaccine Over 90% Effective, Study Shows The biotech firm says the vaccine uses a third type of technology.

By Euni Han

Opinions expressed by Entrepreneur contributors are their own.

SOPA Images | Getty Images

Novavax's COVID-19 vaccine showed an overall efficacy of 90.4% in trials and offered 100% protection in some cases, says CEO Stanley Erck in a company release.

"These clinical results reinforce that NVX-CoV2373 is extremely effective and offers complete protection against both moderate and severe COVID-19 infection," he wrote.

The vaccine also demonstrated 93% efficacy against circulating variants, says Dr. Gregory M. Glenn, Novovax's President of Research and Development.

Related: Grocery Chain to Give Away $5 million to Vaccinated Customers

"These data show consistent, high levels of efficacy and reaffirm the ability of the vaccine to prevent COVID-19 amid ongoing genetic evolution of the virus. Our vaccine will be a critical part of the solution to COVID-19 and we are grateful to the study participants and trial staff who made this study possible."

The trial included 29,960 volunteers in the U.S. and Mexico: 20% were Latin American, 12% were African American, 7% were Native American, 5% were Asian and 13% were over 65 years old. None of the participants receiving the drug fell seriously ill.

Related: These 7 Countries are Now Accepting Vaccine Passports

Common side effects included pain around the injection site, muscle aches and fatigue.

Novavax says its vaccine uses a third type of technology that delivers the protein antigen directly inside the body within tiny particles. A booster then strengthens the body's immune response.

The Gaithersburg, Maryland firm, which received $1.6 billion in federal funding, also says its drug development took longer due to its smaller size, USA TODAY reports.

But once final chemistry, manufacturing and controls requirements are met, Novavax plans to file for regulatory authorization during the summer --- saying its on track to manufacture 100 million doses a month by the end of the third quarter, and 150 million doses a month by the final quarter of 2021.

Related: This robot will tell you when and how to get vaccinated

Editor's Pick

Related Topics

Business News

Photos Leak of McDonald's New Space Age Spinoff Restaurant 'CosMc's'

The mega fast food chain is experimenting with a galactic-themed restaurant, drawing inspiration from an alien character featured in its 1980s commercials.

Side Hustle

This Millennial Dad Just Wanted to Help His Daughter Care for Her Bearded Dragon. Then His Cricket-Breeding Side Hustle Exploded — Earning $27,000 in One Month.

It wasn't Jeff Neal's first attempt at a side gig, and before long, the "prototypical millennial side-hustler" realized his product had major potential.

Health & Wellness

Embrace the Art of Saying No: 4 Tips for Setting Healthy Boundaries

Enforcing your own boundaries can be hard, but it's so important to master this skill. If you practice these four steps, you'll find it doesn't have to be so difficult.

Business News

Chipotle Customer Throws Food At Employee in Brawl, Judge Offers Employment Instead of Jail Time

The video of the September 5 altercation quickly went viral on Reddit.

Leadership

4 Out of 5 Entrepreneurs Step Down as CEO — Here Are 3 Things You Need to Do So You're Not One of Them.

Navigating the journey from entrepreneur to CEO is a profound transformation, one that often separates visionary founders from effective business leaders.